Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Real-World Data of High-Grade Lymphoma Patients Treated with CD19 CAR-T in England

Blood (2019) 134 (Supplement_1): 767.

https://doi.org/10.1182/blood-2019-124177

Published: 2019

Journal Articles

Catheter Directed Thrombolytic Therapy for Pediatric Cerebral Sinus Vein Thrombosis

Marcela Torres, MD, Tyler Hamby, PhD, Sarah Philip, MDcal Student, Jo Ann Tilley, DNP, APRN, CPNP

Blood (2019) 134 (Supplement_1): 3666.

https://doi.org/10.1182/blood-2019-132082

Published: 2019

Journal Articles

Characteristics of Patients with Relapsed/Refractory Burkitt Non-Hodgkin Lymphoma (NHL): Impact on the Feasibility of CAR-T Cell Therapy

Sonia Fortin Gamero, MD, Yi Lin, MD PhD, Saad S. Kenderian, MD, N. Nora Bennani, MD, Gita Thanarajasingam, MD, Thomas M. Habermann, MD, Grzegorz Nowakowski, MD, Thomas E. Witzig, MD

Blood (2019) 134 (Supplement_1): 5352.

https://doi.org/10.1182/blood-2019-131080

Published: 2019

Journal Articles

Impact of Idelalisib Treatment Interruption with or without Dose Reduction on Outcomes in Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Shuo Ma, MD PhD, Rebecca J Chan, MD PhD, Lin Gu, MS, Guan Xing, PhD, Nishan Rajakumaraswamy, MD, Bianca Ruzicka, PhD, Nina D. Wagner-Johnston, MD

Blood (2019) 134 (Supplement_1): 5468.

https://doi.org/10.1182/blood-2019-124541

Published: 2019

Journal Articles

Outcomes of IDH -Mutated Advanced Phase Ph-Negative Myeloproliferative Neoplasms Treated with IDH Inhibitors

Kirk Cahill, MD, Anand Ashwin Patel, MD, Hongtao Liu, MD PhD, Sandeep Gurbuxani, MBBS, PhD, Michael Thirman, MD, Satyajit Kosuri, MD, Andrew S. Artz, MD, Richard A. Larson, MD, Wendy Stock, MD, Jeremy Segal, MD PhD, Olatoyosi Odenike, MD

Blood (2019) 134 (Supplement_1): 4176.

https://doi.org/10.1182/blood-2019-122380

Published: 2019

Journal Articles

Preliminary Results of a Phase 2a Dose Optimization Study of ASLAN003 (DHODH inhibitor) in Acute Myeloid Leukemia (AML) Patients Who Are Ineligible for Standard Therapy; Early Signs of Activity

Stephen B Ting, MB BS, FRACP, FRCPA, PhD, Chin Hin Ng, MD MRCP, Ashish Bajel, MBBS, FRACP, FRCPA, William YK Hwang, MBBS, FRCP(London), MMed(Int MD, FAMS, Shir-Jing Ho, MBBS, FRACP, FRCPA, MClinTrial Res, Wee-Joo Chng, MBBS, PhD FRCPath, FRCP, Mark McHale, B.S., PhD, Chih-Yi Hsieh, MD, Hsuan-Jen Shih, MD, Nicola McIntyre, PhD, Jamie Kwek, Wei-Ling Chang, PhD, Bertil Lindmark, MD PhD

Blood (2018) 132 (Supplement 1): 2676.

https://doi.org/10.1182/blood-2018-99-110570

Published: 2018

Journal Articles

Tumor Associated Macrophages (TAM) Antagonize Chimeric Antigen Receptor (CAR) T Cell Therapy in Peritoneal Solid Tumors and Are Reprogrammed to Fight the Tumor By Therapeutic Apoptotic Cells

Netanel Karbian, PhD, Raja Amore, MsC, Dror Mevorach, MD

Blood (2018) 132 (Supplement 1): 5377.

https://doi.org/10.1182/blood-2018-99-120280

Published: 2018

Journal Articles

Cardiomyopathy Associated with Worsening Intravascular Hemolysis in Transgenic Knock-in Mouse Model of Sickle Cell Disease

Maureen Mburu, MD, Rafey Feroze, BS, Daniel Whitehurst, BS, Xucai Chen, PhD, Samit Ghosh, PhD, Solomon Fiifi Ofori-Acquah, PhD, Flordeliza S Villanueva, MD

Blood (2017) 130 (Supplement 1): 3512.

https://doi.org/10.1182/blood.V130.Suppl_1.3512.3512

Published: 2017

Journal Articles

Prevalence of Stronglyoides Stercoralis and Elevated Immunoglobulin E in Patients with Eosinophilia in a New York City Physician's Practice

Mala Varma, MD, Aungthet Min, Joseph Yoe, MD

Blood (2017) 130 (Supplement 1): 4808.

https://doi.org/10.1182/blood.V130.Suppl_1.4808.4808

Published: 2017

Journal Articles

Safety and Efficacy of B-Cell Maturation Antigen (BCMA)-Specific Chimeric Antigen Receptor T Cells (CART-BCMA) with Cyclophosphamide Conditioning for Refractory Multiple Myeloma (MM)

Blood (2017) 130 (Supplement 1): 505.

https://doi.org/10.1182/blood.V130.Suppl_1.505.505

Published: 2017

Journal Articles

National Early Warning Score (NEWS) and Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Validation in AML Patient during Febrile Neutropenia

Barbara Nicolino, MD, Umberto Vitolo, MD, Ernesta Audisio, Stefano D'Ardia, Chiara Frairia, MD, Giorgia Iovino, MD, Andrea Evangelista, MSc, Giovannino Ciccone, Semra Aydin

Blood (2017) 130 (Supplement 1): 5016.

https://doi.org/10.1182/blood.V130.Suppl_1.5016.5016

Published: 2017

Journal Articles

Oncolytic Reovirus Immune Priming: A Phase 1b Study of Reolysin with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Kevin R. Kelly, MD PhD, Kaijin Wu, PhD, Denice Tsao-Wei, Susan Groshen, Timothy Junius Triche, Jr., PhD, Ann Mohrbacher, Grace Chang, MD, Donna Fernando, Imran N Siddiqi, MD PhD, Matt Coffey, George Gill, Amy Lee, Jennifer S. Carew, PhD, Steffan T. Nawrocki, PhD

Blood (2016) 128 (22): 4507.

https://doi.org/10.1182/blood.V128.22.4507.4507

Published: 2016

Journal Articles

Temporary and Permanent Inferior Vena Cava Filters in the Oncology Population

Suneel Deepak Kamath, MD, Elizabeth H. Cull, MD, Brady L. Stein, MD, Robert Lewandowski, MD, Brandon McMahon, MD

Blood (2016) 128 (22): 1423.

https://doi.org/10.1182/blood.V128.22.1423.1423

Published: 2016

Journal Articles

New Myeloma Diagnostic Criteria: To Treat or Not to Treat? Monocentric Experience of 220 Newly Multiple Myeloma Diagnosed Patients Retrospectively Analyzed

Lorenza Torti, MD, Stefano Pulini, MD, Anna Maria Morelli, MD, Francesco Bacci, MD, Paolo Di Bartolomeo, MD

Blood (2016) 128 (22): 5629.

https://doi.org/10.1182/blood.V128.22.5629.5629

Published: 2016

Journal Articles

Outcome of acute Myeloid Leukemia in Adults Patients Treated According to Morocco National AML-MA-2011 Protocol in Casablanca, Morocco

Romaric Massi, Resident physician, Mouna Lamchahab, MD, Hanaa Bencharef, Resident Physician, Bienvenu Houssou, resident, Nisrine Khoubila, MD, Siham Cherkoui, MD, Meryem Qachouh, MD, Mohamed Rachid, MD, Abdallah Madani, MD, Uma H. Athale, MD, M.Sc., Asmaa AQ Quessar, MD

Blood (2016) 128 (22): 5173.

https://doi.org/10.1182/blood.V128.22.5173.5173

Published: 2016

Journal Articles

Evaluation of Mortality during Treatement of Acute Myeloid Leukemia in Patients According to Morocco National AML-MA-2011 Protocol in Casablanca

Romaric Massi, Resident physician, Mouna Lamchahab, MD, Bienvenu Houssou, resident, Nisrine Khoubila, MD, Siham Cherkoui, MD, Meryem Qachouh, MD, Mohamed Rachid, MD, Abdallah Madani, MD, Uma H. Athale, MD, M.Sc., Asmaa AQ Quessar, MD

Blood (2016) 128 (22): 5177.

https://doi.org/10.1182/blood.V128.22.5177.5177

Published: 2016

Journal Articles

Impact of Surveillance Stool Culture Guided Selection of Antibiotics in Allogeneic Hematopoietic Stem Cell Transplant Patients

Davinder Paul, MD, Anant Ganesh Gokarn, MD DM, Vasudev Bhat, MD, Vivek Bhat, MD, Avinash Bonda, MD, Saurabh Zanwar, MD, Libin Mathew, Sadhana Kannan, Deepa Susan, MD DM, Tapan Saikia, MD, Navin Khattry, MD DM

Blood (2016) 128 (22): 3389.

https://doi.org/10.1182/blood.V128.22.3389.3389

Published: 2016

Journal Articles

Results of a Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients (Pts) with Activating FLT3 Mutations

Jasleen K. Randhawa, MD, Hagop M. Kantarjian, MD, Gautam Borthakur, MD, Philip Alastair Thompson, MBBS,FRCPA,FRACP, Maria Konopleva, MD PhD, Naval Daver, MD, Naveen Pemmaraju, MD, Elias Jabbour, MD, Tapan M. Kadia, MD, Zeev Estrov, MD, Abhijit Ramachandran, PhD, Jamil Paradela, Michael Andreef, MD PhD, Mark Levis, MD PhD, Farhad Ravandi, MD, Jorge E. Cortes, MD

Blood (2014) 124 (21): 389.

https://doi.org/10.1182/blood.V124.21.389.389

Published: 2014

Journal Articles

Temporary Vena Cava Filters in Oncology Patients

Elizabeth H Cull, MD, Robert Lewandowski, MD, Brady L Stein, MD, Brandon McMahon, MD

Blood (2014) 124 (21): 4247.

https://doi.org/10.1182/blood.V124.21.4247.4247

Published: 2014

Journal Articles

Allogeneic Transplantation with CCR5 Δ32/Δ32 Cord Blood Hematopoietic Cells in a HIV-Infected Patient

Rafael F. Duarte, MD PhD, María Salgado, PhD, Isabel Sánchez-Ortega, MD PhD, Montserrat Arnan, MD PhD, Carmen Canals, MD PhD, Eva Domingo, MD, Alberto Fernández de Sevilla, MD PhD, Xavier García-Pont, MD, Eva González-Barca, MD PhD, Sara Morón-López, PhD, Nuria Nogues, MD, Beatriz Patiño, RN, Maria Carmen Puertas, PhD, Bonaventura Clotet, MD PhD, Lawrence D. Petz, MD, Sergio Querol, MD PhD, Javier Martinez-Picado, PhD

Blood (2014) 124 (21): 1261.

https://doi.org/10.1182/blood.V124.21.1261.1261

Published: 2014

NARROW

Real-World Data of High-Grade Lymphoma Patients Treated with CD19 CAR-T in England

Catheter Directed Thrombolytic Therapy for Pediatric Cerebral Sinus Vein Thrombosis

Characteristics of Patients with Relapsed/Refractory Burkitt Non-Hodgkin Lymphoma (NHL): Impact on the Feasibility of CAR-T Cell Therapy

Impact of Idelalisib Treatment Interruption with or without Dose Reduction on Outcomes in Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Outcomes of IDH -Mutated Advanced Phase Ph-Negative Myeloproliferative Neoplasms Treated with IDH Inhibitors

Preliminary Results of a Phase 2a Dose Optimization Study of ASLAN003 (DHODH inhibitor) in Acute Myeloid Leukemia (AML) Patients Who Are Ineligible for Standard Therapy; Early Signs of Activity

Tumor Associated Macrophages (TAM) Antagonize Chimeric Antigen Receptor (CAR) T Cell Therapy in Peritoneal Solid Tumors and Are Reprogrammed to Fight the Tumor By Therapeutic Apoptotic Cells

Cardiomyopathy Associated with Worsening Intravascular Hemolysis in Transgenic Knock-in Mouse Model of Sickle Cell Disease

Prevalence of Stronglyoides Stercoralis and Elevated Immunoglobulin E in Patients with Eosinophilia in a New York City Physician's Practice

Safety and Efficacy of B-Cell Maturation Antigen (BCMA)-Specific Chimeric Antigen Receptor T Cells (CART-BCMA) with Cyclophosphamide Conditioning for Refractory Multiple Myeloma (MM)

National Early Warning Score (NEWS) and Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Validation in AML Patient during Febrile Neutropenia

Oncolytic Reovirus Immune Priming: A Phase 1b Study of Reolysin with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Temporary and Permanent Inferior Vena Cava Filters in the Oncology Population

New Myeloma Diagnostic Criteria: To Treat or Not to Treat? Monocentric Experience of 220 Newly Multiple Myeloma Diagnosed Patients Retrospectively Analyzed

Outcome of acute Myeloid Leukemia in Adults Patients Treated According to Morocco National AML-MA-2011 Protocol in Casablanca, Morocco

Evaluation of Mortality during Treatement of Acute Myeloid Leukemia in Patients According to Morocco National AML-MA-2011 Protocol in Casablanca

Impact of Surveillance Stool Culture Guided Selection of Antibiotics in Allogeneic Hematopoietic Stem Cell Transplant Patients

Results of a Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients (Pts) with Activating FLT3 Mutations

Temporary Vena Cava Filters in Oncology Patients

Allogeneic Transplantation with CCR5 Δ32/Δ32 Cord Blood Hematopoietic Cells in a HIV-Infected Patient

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only